159 related articles for article (PubMed ID: 20617139)
21. A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.
Hoft DF; Blazevic A; Stanley J; Landry B; Sizemore D; Kpamegan E; Gearhart J; Scott A; Kik S; Pau MG; Goudsmit J; McClain JB; Sadoff J
Vaccine; 2012 Mar; 30(12):2098-108. PubMed ID: 22296955
[TBL] [Abstract][Full Text] [Related]
22. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
Xu Y; Wang B; Chen J; Wang Q; Zhu B; Shen H; Qie Y; Wang J; Wang H
Scand J Immunol; 2006 Nov; 64(5):476-81. PubMed ID: 17032239
[TBL] [Abstract][Full Text] [Related]
23. Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex.
Farsiani H; Mosavat A; Soleimanpour S; Sadeghian H; Akbari Eydgahi MR; Ghazvini K; Sankian M; Aryan E; Jamehdar SA; Rezaee SA
Mol Biosyst; 2016 Jun; 12(7):2189-201. PubMed ID: 27138226
[TBL] [Abstract][Full Text] [Related]
24. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
[TBL] [Abstract][Full Text] [Related]
25. [Preparation of TAT-Ag85B protein vaccine and evaluation of its anti-Myobacterium tuberculosis effect].
Zhang R; Wang W; Hu D; Wang W; Xing Y; He J; Dai J; Wu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):49-53. PubMed ID: 25575059
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.
Olsen AW; Williams A; Okkels LM; Hatch G; Andersen P
Infect Immun; 2004 Oct; 72(10):6148-50. PubMed ID: 15385521
[TBL] [Abstract][Full Text] [Related]
28. [Constructing shuttle plasmid fusion expressing Ag85B-ESAT-6 on the surface of Mycobacterium].
Shi CH; Fan XL; Shi JR; Xu ZK; Li Y; Bai YN; Xun Y
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):249-52. PubMed ID: 15144616
[TBL] [Abstract][Full Text] [Related]
29. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
30. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
[TBL] [Abstract][Full Text] [Related]
31. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
Aagaard C; Hoang TT; Izzo A; Billeskov R; Troudt J; Arnett K; Keyser A; Elvang T; Andersen P; Dietrich J
PLoS One; 2009 Jun; 4(6):e5930. PubMed ID: 19529771
[TBL] [Abstract][Full Text] [Related]
32. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y
Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
[TBL] [Abstract][Full Text] [Related]
34. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
35. Enhanced anti-tuberculosis immunity by a TAT-Ag85B protein vaccine in a murine tuberculosis model.
Dong H; Jing W; Yingru X; Wenyang W; Ru C; Shengfa N; Congjing X; Jingjing D; Wan W; Jiang H; Rongbo Z
Pathog Glob Health; 2015; 109(8):363-8. PubMed ID: 26924346
[TBL] [Abstract][Full Text] [Related]
36. Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Guérin.
Shi C; Wang X; Zhang H; Xu Z; Li Y; Yuan L
Acta Biochim Biophys Sin (Shanghai); 2007 Apr; 39(4):290-6. PubMed ID: 17417685
[TBL] [Abstract][Full Text] [Related]
37. ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.
Hoang T; Aagaard C; Dietrich J; Cassidy JP; Dolganov G; Schoolnik GK; Lundberg CV; Agger EM; Andersen P
PLoS One; 2013; 8(12):e80579. PubMed ID: 24349004
[TBL] [Abstract][Full Text] [Related]
38. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c].
Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X
Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525
[TBL] [Abstract][Full Text] [Related]
39. Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis.
Karbalaei M; Mosavat A; Soleimanpour S; Farsiani H; Ghazvini K; Amini AA; Sankian M; Rezaee SA
Curr Microbiol; 2024 Apr; 81(5):127. PubMed ID: 38575759
[TBL] [Abstract][Full Text] [Related]
40. H1:IC31 vaccination is safe and induces long-lived TNF-α
Mearns H; Geldenhuys HD; Kagina BM; Musvosvi M; Little F; Ratangee F; Mahomed H; Hanekom WA; Hoff ST; Ruhwald M; Kromann I; Bang P; Hatherill M; Andersen P; Scriba TJ;
Vaccine; 2017 Jan; 35(1):132-141. PubMed ID: 27866772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
